Adicon Holdings Limited (HKG:9860)
Hong Kong · Delayed Price · Currency is HKD 4.000
-0.005 (-0.12%)
Sep 11, 2026, 4:08 PM HKT
Adicon Holdings Revenue
Adicon Holdings had revenue of 1.28B CNY in the half year ending June 30, 2026, a decrease of -12.34%. This brings the company's revenue in the last twelve months to 2.65B, down -2.44% year-over-year. In the year 2025, Adicon Holdings had annual revenue of 2.64B, down -9.46%.
Revenue (ttm)
2.65B CNY
Revenue Growth
-2.44%
P/S Ratio
0.94
Revenue / Employee
528.00K CNY
Employees
5,024
Market Cap
2.87B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.64B | -275.66M | -9.46% |
| Dec 31, 2024 | 2.91B | -383.72M | -11.64% |
| Dec 31, 2023 | 3.30B | -1.56B | -32.15% |
| Dec 31, 2022 | 4.86B | 1.48B | 43.83% |
| Dec 31, 2021 | 3.38B | 637.78M | 23.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| WuXi XDC Cayman | 8.02B |
| Kindstar Globalgene Technology | 1.10B |
| Yunkang Group | 624.49M |
| Mega Genomics | 413.73M |
| Biosino Bio-Technology and Science Incorporation | 196.98M |
| Zhong Ji Longevity Science Group | 150.07M |
| King International Investment | 143.23M |
| Guanze Medical Information Industry (Holding) | 98.16M |